0.22 m) immediately prior to use Aliquot and store reconstituted solutions at 20 C (or lower) to minimise degradation Avoid repeated freezethaw cycles Due to reported low intrinsic stability in vitro, prepare fresh working solutions when possible Specifications Summary Precautions & Notes Experimental behaviour of DSIP is dependent on concentration, exposure duration, and model system Buffer composition, pH, and enzymatic activity may influence peptide stability Due to reported rapid degradation in some in vitro systems, appropriate controls are recommended Literature reports describe heterogeneous and sometimes contradictory findings across models Intended strictly for laboratory research use
Preclinical Evidence Comparison Multiple independent preclinical and in vitro studies have confirmed the significant advantages of SAG in terms of bioavailability
Gi truyn trng da ny ph thuc rt nhiu cht truyn trng
& Thaiss, C
Tiwari, U.P., et al
Ingredients: water, maltodextrin, dextrose, fructose, L-choline bitartrate, L-carnitine, acidity regulator (trisodium citrate), salt (sodium chloride), vitamin C (sodium ascorbate), natural flavoring, preservative (potassium sorbate), gelling agents (gellan gum, xanthan gum), green tea extract (Camellia sinesis), sweetener (sucralose)